OCT Technology for Keratoconus
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine if OCT technology (a type of imaging) can enhance the fitting of scleral contact lenses for individuals with specific eye conditions. These conditions include keratoconus (a thinning of the cornea), complications after eye surgeries like LASIK, or other surface issues requiring special contact lenses. The trial compares traditional lens fitting with a new method using OCT to identify which is more effective. Suitable participants need scleral lenses due to the mentioned conditions and must not have other serious eye problems like retinal diseases or glaucoma.
As a Phase 2 trial, this research measures the effectiveness of the new OCT method in an initial, smaller group, offering participants the potential benefit of improved lens fitting.
Do I need to stop my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the trial coordinators or your doctor.
What prior data suggests that OCT technology is safe for optimizing scleral contact lens fittings?
Research has shown that scleral lenses are generally safe for people with various eye conditions. A study on patients with keratoconus, a condition affecting the cornea's shape, confirmed that these lenses are safe and effective over time. Another source stated that scleral lenses are as safe as other approved contact lenses for extended wear.
In children, scleral lenses have also proven safe and effective for treating eye surface diseases and irregularly shaped corneas. Although fitting the lenses can present challenges and minor complications may occur, the risk of serious infections remains low. Overall, scleral lenses are well-tolerated and considered safe for various eye conditions.12345Why are researchers excited about this trial?
Researchers are excited about the use of wide-field OCT (optical coherence tomography) for scleral lens fitting because it offers a new way to precisely map the eye's surface. Unlike traditional fitting methods that rely on less detailed imaging, wide-field OCT provides a comprehensive view, allowing for more accurate and personalized lens fitting. This could lead to improved comfort and vision quality for patients using scleral lenses, which are often prescribed for conditions like keratoconus and severe dry eye. By enhancing the fitting process, this technique has the potential to significantly improve patient outcomes and satisfaction compared to current standard practices.
What evidence suggests that OCT technology is effective for optimizing scleral contact lens fittings?
Studies have shown that scleral lenses, evaluated in this trial, can greatly improve vision for individuals with certain eye conditions, such as keratoconus or post-surgery issues. For instance, one study found that scleral lenses improved vision by an average of 3.3 lines on an eye chart compared to regular glasses or contacts. Another study demonstrated that 22% more people achieved 20/20 vision or better with scleral lenses. These lenses also reduce the need for additional eye treatments by about 60%. Overall, scleral lenses effectively provide better vision and comfort for those with specific eye conditions.678910
Who Is on the Research Team?
David Huang, MD, PhD
Principal Investigator
Oregon Health and Science University
Are You a Good Fit for This Trial?
Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Lens Fitting
Participants undergo scleral lens fitting using both clinically-selected and OCT-selected methods
Follow-up
Participants are monitored for lens fit quality and safety over time
What Are the Treatments Tested in This Trial?
Interventions
- OCT Technology
- Scleral Lens Fitting
Find a Clinic Near You
Who Is Running the Clinical Trial?
Oregon Health and Science University
Lead Sponsor
National Eye Institute (NEI)
Collaborator